Offering a range of contract research services for the biomedical research market, TissueVision is anchored in automated, high-throughput instrumentation and services for subcellular fluorescent imaging of tissues and organs in 3D for small mammalian models. The firm's personnel work with pharmaceutical and biotechs to develop custom tissue assays and instrumentation for their specific needs. TissueCyte - the firm's novel turn-key, fully automated platform that can image entire organs in as as little as 4 hours -- is installed in laboratories throughout the world and has been a factor in publications in journals such as Nature and Neuron. Currently in use by research groups in fields as diverse as heart disease, cancer metastasis and diabetes, the firm's systems hold a share of the lucrative pharmaceutical biomedical tissue market - providing whole organ and tissue imaging and analysis of preclinical animal models. The firm's patented technology allows for fully automated, high throughput fluorescence sub-micron imaging that reveals multispectral biochemical signature across whole 3D organs and tissues. Contract research offerings include turn-key package that effectively turns raw samples or chemical matter into a single comprehensive imaging and analysis reports. The resulting data can be used comprehensively to evaluate animal models of disease or profile novel treatments at the whole organ and tissue level using a number of clinically relevant biomarkers.
